BLOG / 🇺🇸 United States / earnings results · · daily

US Earnings Financial Results SEC Filings — November 04, 2026

Financial Results & Earnings

By Gunpowder Editorial ·

50 high priority 50 total filings analysed

Executive Summary

The Q3 2026 earnings season reveals a bifurcated market: high-growth AI and semiconductor companies (AMD, Arista Networks, Astera Labs) are delivering exceptional revenue expansion (44-153% YoY), but even they face margin compression from surging R&D and cost of goods sold.

Conversely, a broad swath of industrials, consumer goods, and financial services firms are reporting 'growth without earnings'—top-line expansion is being consumed by rising interest expenses, acquisition-related costs, and goodwill impairments. A significant theme is the normalization of tax benefits, with several companies (Duolingo, Flywire, Bristow Group) showing optically strong net income growth that is entirely tax-driven, masking underlying operating weakness. Insider trading data is sparse, but capital allocation patterns reveal aggressive M&A (ESAB, Primoris) and share buybacks (Toast, United Therapeutics) that are draining cash reserves and increasing leverage. The most actionable intelligence lies in identifying companies where revenue growth is translating into genuine operating leverage (SharkNinja, Toast) versus those where it is being absorbed by structural costs (Smurfit Westrock, Sysco).

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: 10-Q

Tracking the trend? Catch up on the prior US Earnings Financial Results SEC Filings digest from October 28, 2026.

Investment Signals (10)

  • ▲

    Revenue surged 58.5% YoY to $3.66B with net income up 82.9%, driven by AI networking demand. Despite margin compression, operating cash flow of $3.98B signals strong business model scalability

  • ▲

    Net income grew 79.3% YoY on 21.2% revenue growth, with gross margin expanding from 50.1% to 59.2%. This demonstrates exceptional operating leverage and pricing power in consumer durables

  • ▲

    Revenue grew 21.3% YoY with operating income nearly doubling to $165M. However, $486M in share buybacks (9x YoY increase) signals management confidence but also a cash drain that requires monitoring

  • AMD (MIXED)
    ▲

    Revenue grew 45% YoY to $13.4B with net income up 95%, but Q3 other expense swung to $(902)M from +$82M, and a $(555)M tax benefit flattered results. Core operating leverage is weaker than headline suggests

  • ▲

    Revenue grew 25.1% YoY, but net income was boosted by a $22.2M tax benefit versus a $1.6M provision last year. Pre-tax income rose only 67.8%, indicating the bottom-line jump is largely non-operational

  • Net investment income surged 703% YoY to $9.2M, but NAV per share declined from $25.24 to $24.57, and cash collapsed from $137M to $8.2M, signaling dilution and liquidity risk

  • Net sales rose 53% YoY, but a $779M loss from investment activities drove a swing from $287M net income to a $225M net loss. Operating businesses are growing, but the investment portfolio is a massive liability

  • Revenue grew 12.2% YoY, but net earnings declined 8.9% as other charges surged 240% and interest expense rose 24.4%. The company is investing heavily (goodwill +$866M) but not seeing earnings leverage

  • ▲

    Net income rose to $18.4M from $5.2M despite a 6.9% revenue decline, driven by a 14.3% reduction in traffic acquisition costs. This shows strong cost control and margin expansion in a shrinking top line

  • Revenue grew 68.5% YoY, but net loss widened 66.7% as SG&A surged 104.8%. Post-IPO cash of $226.6M provides runway, but the burn rate is accelerating faster than revenue

Risk Flags (10)

  • Cash declined from $54.4M to $20.7M with a $49.2M operating cash burn in nine months. At this rate, the company has less than 12 months of liquidity, and the loss of VOWST revenue creates a structural deficit

  • Q3 distributions of $11.75M exceeded net investment income of $4.91M, and nine-month realized losses of $47.23M are 3x the prior year. The distribution policy is unsustainable without asset appreciation

  • Nine-month net income fell 80% despite only a 9.1% revenue decline, as gross margin compressed from 11.2% to 8.1%. The $404.7M in acquisitions is not yet generating returns

  • G&A expense surged 234% to $257.4M, and interest expense rose to $105.5M from $8.6M, following $7.7B in debt issuance. The digital asset gains are masking a structurally unprofitable core business

  • Brink's Co/Earnings Collapse [HIGH RISK]
    ▼

    Net income dropped 60% YoY despite 3% revenue growth, as SG&A rose 12.6% and nonoperating expenses swung to a $24.7M loss from $1.5M income. The operating model is under severe cost pressure

  • Cash fell 85.7% to $5.4M while accounts payable nearly doubled to $29M. Despite 54.4% revenue growth, operating income fell 38.2%, and the company is financing growth through supplier credit

  • Despite 2% revenue growth, gross profit fell 8.2% and operating profit declined 7.4%. Both North America and Europe segments saw EBITDA declines, indicating systemic input cost pressures

  • A $541M goodwill impairment drove a $862M net loss, and U.S. sportsbook revenue declined 4.4% YoY. With goodwill still at $15B, further impairments could be material

  • ▼

    Revenue grew 23.8% YoY, but net income fell 9.1% as SG&A rose 53.2% and D&A rose 53.4%. The acquisition strategy is boosting top line but destroying margins

  • ▼

    Weighted average shares rose from 2.0M to 7.7M, and the $26.8M net income is entirely from a non-cash tax benefit. The operating business is still loss-making, and existing shareholders have been massively diluted

Opportunities (10)

  • Revenue grew 153.6% YoY to $584.9M, with net income doubling to $182.9M. Despite gross margin compression from 76.3% to 72.2%, the company is gaining share in the AI connectivity market at a pace that justifies premium valuation

  • Gross margin expanded 910 bps to 59.2% while cost of sales declined 0.8% YoY, demonstrating unique pricing power in a challenging consumer environment. Nine-month net income grew 32.1%

  • Subscription revenue grew 30% and fintech solutions grew 20.3%, driving 25.7% gross profit growth. The aggressive buyback ($486M) suggests management sees intrinsic value, and the business model is generating operating leverage

  • Net income tripled despite a 6.9% revenue decline, driven by a 14.3% reduction in traffic acquisition costs. If the company can stabilize revenue while maintaining cost discipline, margin expansion could be significant

  • AMD/AI Chip Momentum (OPPORTUNITY)
    ◆

    Revenue grew 45% YoY with operating income up 123%. The $(902)M other expense is a one-off swing, and the core business is scaling rapidly. If tax benefits normalize, the underlying earnings power is substantial

  • With $226.6M in cash post-IPO and 68.5% revenue growth, the company has capital to invest in sales infrastructure. The challenge is converting SG&A spend into operating leverage, but the top-line trajectory is compelling

  • Operating cash flow of $3.98B on $9.4B in nine-month revenue (42% cash conversion) is exceptional. The company is funding its own growth without debt reliance, a rare quality in high-growth tech

  • Revenue grew 14.8% YoY with net income up 117%, and cash from operations tripled to $57.3M. In a low-volatility sector, this consistent execution warrants attention

  • ◆

    Net income swung from a $0.5M loss to $3.4M profit, with operating cash flow improving from $(7.5)M to $11.5M. The restructuring charge is small ($0.05M), suggesting the operational fix is sustainable

  • Revenue grew 4.1% with net income up 10.8%, and government payer revenue grew 11.4%. In a defensive sector with steady demand, this consistency provides ballast in a volatile portfolio

Sector Themes (6)

  • AI Infrastructure Outperformance (SECTOR THEME)
    ◆

    Three companies (AMD, Arista, Astera Labs) reported revenue growth of 45-154% YoY, collectively adding over $15B in quarterly revenue. However, all three reported gross margin compression (200-400 bps), indicating that AI buildout is a volume game with pricing pressure

  • The Tax Benefit Mirage (SECTOR THEME)
    ◆

    At least 5 companies (Duolingo, Flywire, Bristow, RYTHM, AMD) showed optically strong net income growth that was entirely or substantially driven by favorable tax items rather than operating improvements. Investors need to strip out tax effects to see true earnings power

  • Growth Without Earnings Syndrome (SECTOR THEME)
    ◆

    12+ companies (Smurfit Westrock, Sysco, EVERTEC, Primoris, Brink's, ESAB) reported revenue growth of 2-24% but saw net income or operating profit decline. The common drivers are rising interest expense (+25-55% YoY), acquisition integration costs, and SG&A inflation

  • Capital Allocation Divergence (SECTOR THEME)
    ◆

    Companies are split between aggressive M&A (ESAB spent $1.47B, Primoris $405M, Talos $440M) and shareholder returns (Toast bought back $486M, United Therapeutics $2B, Cricut paid dividends). The M&A cohort is seeing margin dilution, while buyback companies are showing stronger operating leverage

  • Goodwill Impairment Wave (SECTOR THEME)
    ◆

    At least 4 companies (Owens Corning, CVS Health, Flutter, QuidelOrtho) recorded significant goodwill impairments totaling over $6.6B. This suggests that the 2020-2021 M&A cycle is being written down, and more impairments may be coming across the market

  • Cash Burn vs. Cash Generation (SECTOR THEME)
    ◆

    A clear divide is emerging between companies generating operating cash flow (Arista $3.98B, CVS $15.3B, Toast strong) and those burning cash (Seres $49M, Ultragenyx $337M, Solid Power $44M). The cash generators are investing in growth; the burners are racing against liquidity

Watch List (8)

  • 👁

    Cash runway under 12 months at current burn rate. Watch for Q4 2026 cash position and any partnership/licensing announcements that could provide non-dilutive capital. Next filing likely Q1 2027

  • Distribution coverage ratio is deteriorating. If Q4 2026 realized losses continue at Q3 pace ($11.3M/quarter), the distribution policy may need to be cut. Next earnings call expected late January 2027

  • Toast, Inc.↓ (WATCH)
    👁

    $486M in buybacks has reduced share count but drained cash. Watch for Q4 2026 cash position and whether buyback pace moderates. Any slowdown could signal management concern about liquidity

  • ESAB Corp↓ (WATCH)
    👁

    Integration of $1.47B in acquisitions is compressing margins. Watch for Q4 2026 operating income trends and whether restructuring charges ($39.8M YTD) begin to decline, signaling integration completion

  • With $541M in goodwill impairments and U.S. sportsbook revenue declining, watch for further impairments in Q4 2026. The U.S. sportsbook trend is critical given the FanDuel market position

  • 👁

    $2B in share buybacks reduced shares outstanding by 2.8%, but R&D expense more than doubled. Watch for Q4 2026 revenue trends to see if R&D investment is translating to new product momentum

  • Hut 8 Corp↓ (WATCH)
    👁

    G&A expense growth of 234% and interest expense surge to $105.5M/quarter are unsustainable. Watch for Q4 2026 digital asset gains to see if they can continue to offset operating losses

  • 👁

    Gross margin compression from 11.2% to 8.1% and 80% net income decline signal severe operational stress. Watch for Q4 2026 margin trends and any restructuring announcements

Filing Analyses (50)
Owens Corning 10-Q mixed materiality 8/10

04-11-2026

Owens Corning reported a Q3 2026 net loss of $250M (vs. a $494M loss in Q3 2025) on net sales of $2,489M, down 7.3% YoY from $2,684M. The quarter included a $366M goodwill impairment and a $77M intangible assets impairment. For the nine months, net sales declined 5.7% to $7,510M and net loss narrowed to $127M from $225M, aided by the $364M proceeds from the Glass Reinforcements divestiture; however, gross margin fell 18.0% to $1,918M and operating earnings fell 23.1% to $450M.

  • · Q3 2026 basic and diluted loss per share was $(3.18), vs. $(5.92) in Q3 2025; nine-month diluted loss per share was $(1.61) vs. $(2.63)
  • · Goodwill fell from $1,679M at Dec 31, 2025 to $1,288M at Sept 30, 2026, reflecting impairments and the divestiture
  • · Long-term debt (current + non-current) declined to roughly $4,789M from $5,122M after $400M of debt payments in the nine months
  • · Treasury stock purchases of $502M in the nine months (about 3.8M shares) continued despite the net loss
  • · Q3 2026 income tax expense fell to $33M from $102M, while nine-month tax expense was $150M vs. $300M
  • · Discontinued operations produced a nine-month after-tax loss of $229M (vs. $318M), including a $183M loss from classification as discontinued operations
Taboola.com Ltd. 10-Q mixed materiality 7/10

04-11-2026

Taboola.com Ltd. reported Q3 2026 revenues of $462.3M, down 6.9% from $496.8M in Q3 2025, while net income rose to $18.4M from $5.2M. Nine-month revenues grew 1.2% to $1,405.5M and net income swung to $81.7M from a $7.9M loss, aided by a $77.0M other income item recognized in the first nine months of 2026. Performance is mixed: profitability improved sharply, but top-line revenue declined in the quarter and gross margin/operating expense trends require context.

  • · Q3 2026 operating expenses fell to $125.4M from $132.5M, a 5.3% decline, with sales and marketing down 7.7% and R&D down 3.1%.
  • · Traffic acquisition cost fell 14.3% YoY in Q3, while other cost of revenues declined 4.1%, driving the gross profit increase despite lower revenue.
  • · Nine-month 2026 results include a $77.0M other income, net item; excluding it, nine-month operating income would be about $26.6M versus a $0.3M operating income in 2025.
  • · Finance expense for nine months 2026 was $2.9M versus $6.5M in 2025, and income tax expense rose to $18.9M from $1.6M.
  • · Shares outstanding declined about 8.7% YoY in Q3 weighted-average basic shares, reflecting $94.6M of nine-month repurchases.
  • · Q3 2026 comprehensive income was $16.5M versus $4.0M in Q3 2025, with accumulated other comprehensive loss of $0.4M at period end.
uniQure N.V. 10-Q mixed materiality 7/10

04-11-2026

uniQure N.V. reported Q3 2026 total revenues of $5.2 million, up 40.4% from $3.7 million in Q3 2025, driven by higher license revenues ($5.2M vs. $3.6M, +45.0%). However, the net loss widened to $61.2 million from $80.5 million a year earlier (a 24.0% improvement), while the nine-month net loss rose to $195.8 million from $161.9 million (+20.9%). Operating expenses increased 10.1% in the quarter to $59.7 million, with SG&A up 23.1% while R&D rose only 3.4%; nine-month R&D fell 6.8%, but nine-month SG&A rose 39.9%. Cash, cash equivalents and investment securities totaled about $668.4 million at September 30, 2026 (cash $98.4M, current investments $570.0M, non-current investments $100.0M), versus $622.5 million at year-end 2025, supported by a $242.7 million follow-on offering in the nine months.

  • · Other income fell sharply to $4.9M for nine months 2026 from $12.4M in 2025, while other non-operating losses widened to $13.1M from $7.2M.
  • · Foreign currency swung from a $25.4M gain in 9M 2025 to a $4.2M loss in 9M 2026.
  • · Income tax expense for Q3 2026 was $0.7M versus $8.6M in Q3 2025, a decline of about 92%.
  • · Royalty financing liability grew to $502.1M from $478.7M, with $38.7M of interest expense accrued in 9M 2026 against $15.4M of royalty payments.
  • · Accumulated deficit reached $1.52B, up from $1.33B at year-end 2025.
  • · Pre-funded warrant liability was fully settled by year-end 2026 (from $12.6M at Dec 31, 2025), converted into 526,314 shares.
Seres Therapeutics, Inc. 10-Q negative materiality 8/10

04-11-2026

Seres Therapeutics reported a net loss of $16.3M for Q3 2026 (versus net income of $8.2M in Q3 2025) and a nine-month net loss of $31.6M (versus net income of $21.0M). Results were driven by the absence of the prior-year VOWST sale gain, a $5.7M impairment charge in Q3 and $11.5M year-to-date, and lower R&D and G&A spend. Cash, cash equivalents and restricted cash fell to $20.7M at September 30, 2026, down from $54.4M at December 31, 2025, with a nine-month operating cash outflow of $49.2M.

  • · Nine-month 2026 operating cash burn of $49.2M contrasts with $15.8M of operating cash generation in 2025, reflecting the loss of the VOWST business and lower collections
  • · Operating lease liabilities fell sharply (total from $82.97M to $35.77M), largely from a $30.4M reduction due to lease modification
  • · Leasehold improvements dropped from $30.95M to $3.75M and accumulated depreciation fell, consistent with asset disposals and the impairment charges
  • · Accounts receivable from SPN related party was $12.5M at 9/30/2026, versus $0.36M at 12/31/2025, tied to the VOWST milestone termination payment received in the period
  • · Equity raised via at-the-market offerings was modest ($2.9M net in nine months), with 103,520 shares issued for lease termination valued at $0.5M
  • · Going-concern-style liquidity pressure is implied by cash of $17.5M against a nine-month operating burn of $49.2M, though the filing text itself was not provided to confirm management's conclusions
5C Lending Partners Corp. 10-Q mixed materiality 8/10

04-11-2026

5C Lending Partners Corp. reported total investment income of $20,656 thousand for Q3 2026, up from $6,766 thousand in Q3 2025, and net increase in net assets from operations of $11,867 thousand. Total net assets rose to $432,915 thousand at September 30, 2026 from $241,306 thousand at December 31, 2025, driven by common stock issuance, while NAV per common share declined to $24.57 from $25.24. Net change in unrealized losses for the nine months (-$12,219 thousand) and a $(2,118) thousand accumulated distributable loss weigh on results, even as net investment income expanded sharply.

  • · Net investment income for Q3 2026 was $9,166 thousand versus $1,142 thousand in Q3 2025, but nine-month net investment income of $17,807 thousand reflects a more modest pace of earnings growth relative to the quarter.
  • · Net change in unrealized losses on non-controlled, non-affiliated investments was $(13,838) thousand for the nine months 2026, reversing a $1,054 thousand gain in the prior-year period.
  • · Cash and cash equivalents declined to $8,181 thousand from $137,048 thousand, and net cash used in operating activities was $(516,535) thousand for the nine months, driven by $568,069 thousand of investment purchases and originations.
  • · ABL Credit Facility borrowings rose to $467,000 thousand from $170,000 thousand at year-end 2025, while the Credit Facility declined to $95,769 thousand from $181,968 thousand.
  • · Preferred Stock dividends of $139 thousand for nine months and Q3 2026 Preferred Stock dividends of $46 thousand were paid, with 515 preferred shares outstanding.
  • · The KPCI Holdings Ltd. (PCI Pharma Services) preferred equity position of $58,441 thousand represents 13.55% of net assets applicable to common stock and carries an 11.00% PIK rate.
  • · Flexera Software LLC term loans, Navex Global, and Starlight Parent (SolarWinds, second lien at 9.68% of net assets) are among the largest debt exposures.
Brownie's Marine Group, Inc 10-Q mixed materiality 7/10

04-11-2026

Brownie's Marine Group reported Q3 2026 total revenues of $2,642,325, up 27.6% from $2,071,164 in Q3 2025, and nine-month revenues of $7,135,460, up 16.6% YoY. Net income for the quarter was $659,694 versus $191,666 a year earlier, though a large portion of that improvement came from a $377,576 gain on settlement of debt, while gross profit rose 41.7% and SG&A grew 25.1% to $1,036,547. Cash rose to $790,026 but operating cash flow for the nine months was $711,316 against $61,865 prior year and the company recorded $2,779,582 in new operating lease ROU assets.

  • · Q3 2026 related-party revenues fell 4.6% YoY to $228,035, while third-party revenues rose 31.7%
  • · Q3 2026 Q3 operating income of $310,724 is benefited from strong gross margin expansion, but net income includes a $377,576 debt settlement gain that is non-operating
  • · Nine-month net income of $1,371,382 includes $1,228,604 of debt settlement gains, so operating income of $289,006 is the more representative earnings measure
  • · Basic weighted average shares rose to 556,353,166 in Q3 2026 from 450,656,081, a 23.4% increase in share count that dilutes per-share gains
  • · Nine-month operating cash flow includes a $282,535 prior-period accounting adjustment and a $490,023 increase in payables, which flatter the cash result
  • · Inventory increased 26.0% since December 2025 to $2,948,866, with finished goods up 38.8%, tying up working capital
AtriCure, Inc. 10-Q mixed materiality 6/10

04-11-2026

AtriCure reported Q3 2026 revenue of $154.45M, up 15.0% YoY from $134.27M, and net income of $4.06M versus a net loss of $0.27M in Q3 2025. Nine-month revenue rose 14.0% to $449.30M and nine-month net income was $13.13M versus a $13.20M loss a year earlier. However, Research and development expense rose 40.3% YoY in Q3 to $32.12M, and gross margin compressed slightly to 77.3% from 75.5% expansion-neutral comparison is not applicable, while the company's cash flow from investing rose sharply on higher capex.

  • · Q3 2026 SG&A rose 6.0% YoY to $82.88M, growing slower than revenue, while R&D jumped 40.3%, the main driver of higher operating expenses.
  • · Q3 2026 gross margin was roughly 77.3%, compared with roughly 75.5% in Q3 2025.
  • · Long-term debt was essentially unchanged at $61.00M, while finance and operating lease liabilities more than doubled to $32.11M from $11.52M.
  • · Property and equipment, net rose 70% to $66.67M from $39.12M, consistent with capex of $14.01M in the nine months.
  • · Accumulated deficit narrowed to $(400.08)M from $(413.20)M at year-end 2025.
  • · Foreign currency translation was a $0.55M headwind for the nine months, versus a $1.61M benefit in 2025.
3D SYSTEMS CORP 10-Q mixed materiality 7/10

04-11-2026

3D Systems reported Q3 2026 revenue of $99.3M, up 8.8% YoY from $91.2M, and nine-month revenue of $289.4M, up 3.1% from $280.6M. Net loss attributable to the company widened to $33.5M in Q3 from $18.1M a year earlier, though nine-month results were still affected by a $125.7M gain on disposition recorded in the prior-year period, which swung nine-month net income from $49.4M to a $50.8M loss. Results are mixed: top-line growth and a lower SG&A/R&D base contrast with higher selling, general and administrative expense in Q3, a $6.3M foreign exchange loss, a $2.9M asset impairment charge, and a widening operating loss.

  • · Q3 2026 gross margin expanded to about 35.0% from 32.2%, driven by Products revenue growth of 11.2% YoY.
  • · Services revenue declined 1.0% YoY on a nine-month basis to $118.6M, a flat-to-declining segment despite the Q3 uptick.
  • · Q3 2026 R&D fell 37.2% YoY to $10.1M, while SG&A rose 33.5% to $46.4M, a notable reallocation of spending.
  • · Q3 2026 included a $6.3M foreign exchange loss versus a $2.6M gain in Q3 2025, weighing on non-operating results.
  • · Nine-month 2026 net loss included a $2.9M asset impairment charge recorded in Q3 2026.
  • · Nine-month 2025 results were inflated by a $125.7M non-recurring gain on disposition, making year-over-year profit comparisons unrepresentative.
  • · Cash and cash equivalents declined to $91.3M at September 30, 2026, from $95.6M at year-end 2025, despite $53.8M in equity proceeds.
  • · Stockholders' equity rose to $246.7M from $240.4M at December 31, 2025, driven by equity issuance and offset by accumulated losses.
Motorola Solutions, Inc. 10-Q mixed materiality 9/10

04-11-2026

Motorola Solutions, Inc. reported net sales of $3,376M for Q3 FY26 (quarter ended October 3, 2026), up 12.2% from $3,009M in the prior year quarter, driven by strong growth in both product sales (+14.2%) and services (+9.5%). However, net earnings declined 8.9% YoY to $514M for the quarter, as other charges surged 240% to $211M and interest expense rose 24.4% to $107M, compressing margins. For the nine-month period, net sales grew 11.1% to $9,223M, but net earnings fell 4.6% to $1,440M, reflecting persistent cost pressures.

  • · Total assets grew 9.0% from $19,389M (Dec 31, 2025) to $21,141M (Oct 3, 2026), driven largely by a $866M increase in goodwill and a $398M increase in intangible assets.
  • · Long-term debt increased 11.3% to $9,361M, while cash and cash equivalents declined 33.4% from $1,165M to $774M over the same period.
  • · Net cash provided by operating activities was nearly flat at $1,582M (9M FY26) vs $1,581M (9M FY25), despite higher net earnings adjustments for depreciation and share-based compensation.
  • · Cash paid for interest doubled to $330M in 9M FY26 from $166M in 9M FY25, reflecting higher debt levels.
  • · The company spent $1,587M on acquisitions and investments in 9M FY26, down significantly from $4,835M in 9M FY25.
  • · Share repurchases totaled $543M in 9M FY26, down from $664M in 9M FY25, while dividend payments rose to $602M from $546M.
  • · R&D expenditure increased 16.4% YoY to $276M in Q3 and 12.6% YoY to $788M for the nine-month period.
  • · Other comprehensive income was $18M in Q3 FY26, compared to a loss of $5M in Q3 FY25, primarily due to favorable foreign currency translation adjustments and defined benefit plan changes.
  • · The company's effective tax rate for the quarter was approximately 24.2%, slightly lower than 22.2% in the prior year quarter.
Navient Holdings, Inc. 10-Q mixed materiality 8/10

04-11-2026

Navient Holdings, Inc. reported a GAAP net income of $15M for Q3 2026, a significant turnaround from a net loss of $86M in Q3 2025, driven by $162M in gains on sales of loans and lower operating expenses. However, core earnings net income was only $3M, net interest income declined 19% YoY to $115M, and provisions for loan losses surged 35% to $227M, reflecting ongoing pressure in the lending business. The total education loan portfolio shrank 7% YoY to $41.2B, with FFELP loans declining 11%.

  • · Consumer Lending segment net interest margin declined from 2.39% in Q3 2025 to 2.09% in Q3 2026.
  • · Federal Education Loans segment net interest margin declined from 0.84% in Q3 2025 to 0.69% in Q3 2026.
  • · Total capital returned to shareholders was $25M in Q3 2026, down from $42M in Q3 2025.
  • · Adjusted Tangible Equity Ratio improved to 9.5% from 9.3%.
  • · Private Education Loans originations/purchases increased to $1,137M in Q3 2026 from $687M in Q3 2025.
  • · FFELP loan portfolio declined to $25,898M from $28,952M, a decrease of 11%.
  • · Servicing revenue declined 23% YoY to $10M in Q3 2026.
  • · Revenue from government services was $0 in both Q3 2026 and Q3 2025, compared to $23M in the nine months ended Sep 30, 2025.
Oportun Financial Corp 10-Q mixed materiality 7/10

04-11-2026

Oportun Financial Corp reported Q3 2026 net income of $22.9M (in thousands: $22,931K), up from $5.2M in Q3 2025, and nine-month net income of $33.8M versus $21.8M a year earlier. Total revenue was essentially flat over nine months ($708.3M vs. $708.9M) and rose 3.2% in the quarter to $246.3M, while interest expense fell sharply (down 27.4% in the quarter). However, net decrease in fair value losses widened to $250.1M for nine months (up 13.7% YoY), and total assets declined slightly to $3,213.8M from $3,257.9M at year-end 2025.

  • · Asset-backed notes at fair value fell to $93.5M from $263.8M at year-end 2025, while asset-backed borrowings at amortized cost declined to $2,039.0M from $2,192.6M, reflecting deleveraging of securitization funding.
  • · Nine-month loan originations held for investment were $1,120.6M versus repayments of $971.5M, compared with $1,195.3M originations and $1,033.4M repayments in the prior-year period.
  • · Accumulated deficit narrowed to $(193.5)M from $(227.3)M at year-end 2025, and stockholders' equity increased 11.1% to $433.4M.
  • · Nine-month personnel expense rose 26.4% YoY to $76.1M, a key driver of operating cost pressure despite lower G&A and technology spend.
  • · Consolidated VIE assets increased to $2,766.5M from $2,707.1M, while VIE liabilities rose to $2,484.1M from $2,416.6M.
ADVANCED MICRO DEVICES INC 10-Q mixed materiality 8/10

04-11-2026

AMD reported Q3 2026 net revenue of $13,377M, up 45% YoY from $9,246M, with operating income of $2,832M (up from $1,270M) and net income of $2,428M (up from $1,243M). Nine-month net revenue reached $35,166M (up 44% YoY), and net income was $6,108M versus $2,824M. However, Q3 other expense of $(902)M swung sharply negative from $82M a year earlier, and the effective tax benefit of $(555)M flattered Q3 net income.

  • · Q3 2026 other expense of $(902)M, versus +$82M income in Q3 2025, was the primary drag on pre-tax income and a key negative swing not captured in the headline growth figures.
  • · Q3 2026 gross margin contracted to roughly 53.9% from 51.7% in Q3 2025 on a total-cost basis, while gross profit grew 50.8%; the net-revenue-based gross profit percentage improved, but amortization and cost-of-sales growth outpaced some expectations of margin expansion.
  • · Q3 2026 net income benefited from a $(555)M income tax benefit, versus a $153M tax provision in Q3 2025, so a substantial portion of net income growth came from the tax line rather than operations.
  • · Long-term debt rose to $7,079M from $2,348M, and nine-month debt proceeds were $4,726M, indicating meaningful leverage increase during 2026.
  • · Nine-month non-cash impact of warrants issued to customers was $1,179M, a new item affecting operating cash flow reconciliation.
  • · Nine-month stock repurchases for tax withholding totaled $1,836M (versus $447M), which materially reduced cash available despite operating cash flow of $6,523M.
  • · Accounts payable increased to $7,756M from $2,929M and inventories to $11,463M from $7,920M, indicating working capital build alongside revenue growth.
  • · Finished goods inventory declined 18.2% to $1,835M while work-in-process and raw materials increased, suggesting a shift toward earlier-stage inventory.
Duolingo, Inc. 10-Q mixed materiality 7/10

04-11-2026

Duolingo reported Q3 2026 revenue of $309.0M, up 13.7% YoY from $271.7M, with net income of $27.2M versus $292.2M in the prior-year quarter, which was inflated by a $245.7M tax benefit. Operating income fell 31.2% YoY to $24.2M from $35.2M as R&D (+30.3%) and sales and marketing (+20.2%) expenses outpaced revenue growth, while the company repurchased $6.4M of stock during the quarter.

  • · Q3 2026 gross margin was roughly 72.9% (225.1/309.0), essentially flat versus about 72.5% in Q3 2025.
  • · Q3 2026 R&D expense rose 30.3% YoY to $107.7M, the fastest-growing cost line and roughly 35% of revenue versus 30% a year earlier.
  • · Q3 2026 provision for income taxes was $8.4M, a normalized charge versus a $245.7M benefit in Q3 2025, which drove the optical net income comparison.
  • · Excluding the tax benefit, Q3 2025 net income would have been roughly $46.4M, so underlying Q3 2026 net income declined about 41% YoY.
  • · Nine-month 2026 operating income grew 11.5% YoY to $102.7M, a modest gain versus 19.2% revenue growth.
  • · Stock-based compensation rose to $120.3M for the nine months versus $101.2M a year earlier (+18.9%).
  • · Deferred tax assets, net declined to $203.6M from $227.3M at year-end 2025.
  • · Short-term investments of $134.3M and long-term investments of $110.1M; total cash, equivalents and investments approximately $1.48B.
  • · Cash and cash equivalents grew to $1.24B from $1.04B at December 31, 2025 (+19.6%).
FutureCorp Space Acquisition 1 10-Q mixed materiality 5/10

04-11-2026

FutureCorp Space Acquisition 1, a shell SPAC, reported net income of $1,914,985 for the three months ended September 30, 2026, driven almost entirely by $2,106,084 of interest earned on its Trust Account, against general and administrative fees of $192,397. For the period from inception (March 12, 2026) through September 30, 2026, cumulative net income was $2,003,330 on G&A fees of $594,968, but the company carries a Total Shareholders' Deficit of $(8,858,354) and a working capital deficit, as its balance sheet is dominated by $232,597,000 held in trust and $232,597,000 of Class A shares subject to redemption. Because the company has no operating business, its results depend on trust income and the eventual outcome of its business combination search.

  • · Net income for the quarter was entirely attributable to trust interest income; operating costs of $192,397 were a loss from operations.
  • · Accumulated deficit of $(8,858,929) reflects accretion of Class A shares to redemption value of $10.11 per share, totaling $232,597,000.
  • · Cash of $960,277 is the company's only liquid asset outside the trust, against total current liabilities of $221,850 and a $9,800,000 deferred underwriting fee payable.
  • · Company is classified as a shell company and emerging growth company; securities are listed on the NYSE.
Townsquare Media, Inc. 10-Q mixed materiality 7/10

04-11-2026

Townsquare Media's Q3 2026 10-Q shows net revenue up 3.9% YoY to $110.9M (from $106.8M), but operating income swung to a $5.5M gain versus $5.9M prior year essentially flat, and the company reported a Q3 net loss of $4.0M (vs. $5.5M loss a year earlier). Nine-month results were weaker: revenue was roughly flat at $323.1M (+0.7%), while operating loss widened to $8.1M from $34.1M income, driven by $43.3M of impairments, and the nine-month net loss reached $42.8M versus $5.0M. Stockholders' deficit deepened to $84.9M, and total assets fell to $485.8M from $528.6M.

  • · Nine-month impairment charges of $43.3M (vs. $4.6M prior year) drove the operating loss and are the main reason for the widened net loss.
  • · Subscription Digital Marketing Solutions revenue declined about 8.5% YoY in Q3 2026 ($17.1M vs. $18.6M), the weakest segment.
  • · Broadcast Advertising ex-political revenue fell about 5.2% YoY in Q3 ($44.4M vs. $46.8M); total Broadcast growth was supported by $2.8M of political revenue.
  • · Operating cash flow fell 28% to $12.9M for nine months from $18.0M, and cash ended at $4.6M, nearly flat versus $4.8M at year-end 2025.
  • · Intangible assets dropped to $109.2M from $155.0M, reflecting the impairment charges.
  • · Dividends of $0.20 per share were paid each quarter, totaling $10.9M in cash for nine months, while operating cash flow did not fully cover them.
  • · Transaction and business realignment costs were $1.1M in Q3 2026 vs. $6.9M in Q3 2025, though nine-month costs were $4.4M vs. $10.7M.
EVERTEC, Inc. 10-Q mixed materiality 7/10

04-11-2026

EVERTEC reported Q3 2026 revenues of $282,994 thousand, up 23.8% YoY from $228,587 thousand, and nine-month revenues of $805,737 thousand, up 17.3% YoY. Net income attributable to common stockholders declined to $29,872 thousand in Q3 (down 9.1% YoY from $32,861 thousand) and to $59,028 thousand for nine months (down 44.3% from $106,029 thousand), as SG&A, D&A, and interest expense rose sharply following acquisitions and new long-term debt. Nine-month operating cash flow grew 12.3% to $176,289 thousand, while cash and cash equivalents fell 7.1% from year-end.

  • · Q3 2026 SG&A rose 53.2% YoY to $57,714 thousand, and D&A rose 53.4% YoY to $43,627 thousand, pressuring operating margin despite higher revenue.
  • · Nine-month 2026 income tax expense was $28,056 thousand versus $8,175 thousand in 2025, a major drag on net income.
  • · Long-term debt rose to $1,214,053 thousand from $1,053,030 thousand at year-end, with $184,538 thousand in new debt proceeds in 2026.
  • · Net cash used in investing activities was $261,870 thousand for 9M 2026, driven primarily by $186,617 thousand in acquisitions, net of cash acquired.
  • · Goodwill increased to $1,065,803 thousand from $891,992 thousand, reflecting acquisition activity; a $8,885 thousand impairment on an equity investee was recorded.
  • · Share repurchases totaled $82,477 thousand in cash for 9M 2026 versus $3,691 thousand in 2025.
  • · Foreign currency translation was a $8,512 thousand loss in Q3 2026 versus a $13,593 thousand gain in Q3 2025, though nine-month translation remained a $50,319 thousand gain.
Solid Power, Inc. 10-Q mixed materiality 7/10

04-11-2026

Solid Power reported a Q3 2026 net loss attributable to common stockholders of $24.4 Million, versus a $25.9 Million loss in Q3 2025, and total revenue and grant income of $1.2 Million, down from $4.6 Million a year earlier (-73%). Revenue fell to $243 thousand from $3,732 thousand (-93%), while grant income rose 19% to $981 thousand, and R&D spending was roughly flat at $18.7 Million (+2%) while SG&A climbed 39% to $9.8 Million. Cash, restricted cash and marketable securities totaled about $235.5 Million at September 30, 2026, supported by a $121.3 Million registered direct offering during the nine months, though operating cash burn was $44.0 Million over that period.

  • · Warrant liabilities were fully eliminated from long-term liabilities, with a $13.5 Million non-cash gain on fair value change over nine months providing a meaningful offset to the operating loss
  • · Property, plant and equipment, net declined to $81.1 Million from $86.3 Million, with construction in progress rising to $12.9 Million from $6.9 Million, signaling continued capacity build-out
  • · Accumulated other comprehensive loss swung to $(2.5) Million from a $0.4 Million gain at year-end 2025, reflecting unrealized losses on available-for-sale securities
  • · Contract assets fell to zero from $7.5 Million, and deferred revenue rose to $3.1 Million from $0.2 Million, indicating a shift in the timing of customer billings
  • · Unpaid reimbursements on capital expenditures rose to $4.5 Million from $0.2 Million, a possible future cash outflow not yet reflected in investing cash flows
ICAHN ENTERPRISES L.P. 10-Q mixed materiality 8/10

04-11-2026

Icahn Enterprises reported a Q3 2026 net loss attributable to IEP of $225 million ($0.31 per LP unit), compared with net income of $287 million ($0.49 per LP unit) in Q3 2025. Net sales rose 53% YoY to $3,549 million, but a net loss from investment activities of $779 million (versus a $48 million loss a year earlier) and a $165 million impairment drove the swing to losses. For the nine months, net loss attributable to IEP widened to $1,039 million from $300 million, while operating cash flow improved to $729 million from $108 million.

  • · Cost of goods sold rose to $2,733 million in Q3 2026 from $1,685 million, outpacing sales growth and compressing margins within the operating businesses.
  • · Nine-month net cash used in investing activities turned to a $353 million inflow, driven by $642 million of proceeds from disposition of businesses and assets versus $112 million a year earlier.
  • · Investment segment distributions to non-controlling interests totaled $451 million for nine months 2026 versus $526 million in 2025, and cash financing outflows were $904 million.
  • · Goodwill fell to $105 million from $290 million and intangible assets declined to $279 million from $349 million, reflecting the impairment and asset-level writedowns.
  • · Securities sold, not yet purchased declined to $750 million from $1,382 million, and debt decreased to $6,357 million from $6,616 million.
Alamar Biosciences, Inc. 10-Q mixed materiality 8/10

04-11-2026

Alamar Biosciences reported Q3 2026 total revenue of $33.5M, up 68.5% YoY from $19.9M, with a gross profit of $20.6M versus $11.9M a year earlier. However, net loss widened to $13.3M from $8.0M (a 66.7% increase) as operating expenses rose 80.9% to $35.8M, driven by SG&A growth of 104.8% and R&D growth of 58.4%. Following its IPO, cash and short-term investments reached $226.6M at September 30, 2026, versus $30.0M at year-end 2025.

  • · Q3 2026 SG&A increased 104.8% YoY to $19.6M, the fastest-growing expense line, driving most of the operating loss widening
  • · Interest income rose to $2.2M in Q3 2026 from $0.4M, partly offsetting operating losses
  • · Nine-month 2026 net loss includes a $10.0M non-cash loss on remeasurement of convertible notes
  • · Inventory increased to $54.1M from $38.5M at year-end 2025, and accounts receivable rose to $21.6M from $12.8M, indicating working capital build
  • · Net cash used in operating activities was $46.4M for nine months 2026, up 18.7% from $39.1M
  • · Q3 2026 gross margin was approximately 61.6%, roughly flat versus Q3 2025 gross margin of approximately 59.7%
Cricut, Inc. 10-Q mixed materiality 6/10

04-11-2026

Cricut reported Q3 2026 total revenue of $188.6M, up 10.7% YoY from $170.4M, with net income rising 35.7% to $27.8M and diluted EPS of $0.13 versus $0.10. However, nine-month revenue was essentially flat at $504.4M versus $505.2M (-0.2%), and nine-month operating cash flow fell 14.4% to $100.9M from $117.8M, while cash and cash equivalents declined to $174.6M from $256.2M at year-end.

  • · Nine-month Products revenue declined about 5.0% YoY to $248.7M, offsetting Platform growth of about 5.0% to $255.7M
  • · Nine-month inventories rose to $146.9M from $102.7M at year-end, a cash drag of $28.6M in operating cash flow
  • · Dividends declared in Q2 2026 were $24.3M, and the company recorded no dividends payable at September 30, 2026 versus $24.4M a year earlier
  • · Operating expenses grew 15.4% in Q3 with Sales and Marketing up 10.0%, while G&A fell 2.4% in the quarter and 9.2% for nine months
  • · Remaining deferred revenue of $54.7M is expected to be recognized mostly in the rest of 2026 ($29.5M) and 2027 ($23.2M)
  • · Total stockholders' equity rose to $399.4M from $343.6M, driven by retained earnings growth to $73.4M
Oxford Square Capital Corp. 10-Q mixed materiality 7/10

04-11-2026

Oxford Square Capital Corp. reported Q3 2026 total investment income of $9.91M, down 3.2% from $10.24M in Q3 2025, and net investment income of $4.91M, down 11.6% YoY. Q3 net increase in net assets from operations was $1.56M, a swing from a $2.09M decrease a year earlier, but for the nine months the company recorded a $19.97M net decrease versus a $5.83M decrease in the prior year, driven by $47.23M of realized losses. Net asset value per share fell to $1.21 from $1.69 at year-end 2025 while shares outstanding rose to 120.0M, and the company continued to pay $0.105 per share in quarterly distributions that exceed net investment income.

  • · Q3 2026 realized losses of $11.28M were concentrated in non-affiliated investments, and nine-month realized losses of $47.23M exceeded the full prior-year nine-month figure of $14.68M by more than three times.
  • · Q3 2026 net unrealized appreciation of $7.93M reversed a $7.50M depreciation in Q3 2025, partially offsetting realized losses.
  • · Q3 distributions of $11.75M exceeded Q3 net investment income of $4.91M, and nine-month distributions of $31.53M exceeded nine-month NII of $14.20M.
  • · Equity investment in UniTek Global Services preferred stock carries $0 fair value on the Series B and Series B Senior classes, with only the Series B Super Senior (20% PIK) at $6.82M, versus $5.01M at year-end 2025.
  • · A new $5.00M controlled affiliate investment in Modern Intelligence, Inc. Series A-1 Preferred Stock was added during the period at cost.
  • · Total investments in securities of $260.08M represent 179.0% of net assets, indicating substantial leverage against the $145.38M equity base.
  • · Net assets were roughly flat year-over-year at $145.38M despite $51.47M of capital raised through share issuance and DRIP, because the nine-month net decrease from operations offset those inflows.
TWIN DISC INC 10-Q mixed materiality 6/10

04-11-2026

Twin Disc reported Q1 FY2027 (quarter ended September 25, 2026) net sales of $88.745M, up 10.9% YoY from $79.996M, and net income attributable to Twin Disc of $3.445M versus a $0.518M loss a year earlier, with diluted EPS of $0.24 versus $(0.04). Results were supported by lower interest expense (down 46.5%) and a lower tax charge, while marketing, engineering and administrative expenses were essentially flat (up 0.7%) and the company recorded a $0.052M restructuring charge; operating cash flow of $11.532M compared with a $(7.524)M outflow in the prior year, but capital expenditures rose 68.7% to $5.784M.

  • · Distribution segment net sales were $22.389M after eliminations; Manufacturing segment total consolidated net sales were $66.356M.
  • · Distribution segment net income was $0.551M attributable to Twin Disc versus a corporate segment loss of $(1.167)M.
  • · Total assets were $405.189M at September 25, 2026; cash rose to $26.728M from $16.029M at June 30, 2026, driven by $5.674M of net working capital release and $22.765M of revolver borrowings (partly repaid by $12.765M).
  • · Retained earnings were restated upward under a new inventory accounting method (effect of accounting change of +$25.045M at June 30, 2026), with inventories restated from $145.407M to $178.028M.
  • · Dividend per share increased to $0.05 from $0.04 a year earlier.
  • · Net sales were reported under a new inventory accounting method; prior-period comparatives may not be directly comparable to previously reported figures.
Arista Networks, Inc. 10-Q mixed materiality 8/10

04-11-2026

Arista Networks reported Q3 2026 revenue of $3,657.6 Million, up 58.5% YoY from $2,308.3 Million, with net income of $1,560.4 Million (up 82.9% YoY) and diluted EPS of $1.22 versus $0.67. Nine-month revenue reached $9,402.3 Million (up 44.2%) and operating cash flow was $3,977.4 Million. However, Q3 other comprehensive loss widened to $(60.5) Million and nine-month OCI fell to $(113.0) Million, reversing the prior-year gain, while Q3 product service cost of revenue also rose meaningfully and cash on hand is modest relative to marketable securities.

  • · Balance sheet liquidity is concentrated in marketable securities ($12,070.9 Million) versus cash and equivalents of only $2,288.1 Million.
  • · Inventories rose to $3,209.8 Million from $2,247.1 Million at year-end, up about 42.8%, and nine-month inventory cash outflow was $962.8 Million.
  • · Deferred tax assets fell to $1,437.7 Million from $1,773.6 Million, while the nine-month deferred income tax line was a $369.3 Million non-cash addback.
  • · Nine-month free cash flow approximates $3,792.5 Million after $184.9 Million of capex, and nine-month investing outflow was $3,659.1 Million.
  • · Q3 2026 product cost of revenue grew about 68.3% YoY to $1,255.1 Million, outpacing product revenue growth of about 66.9% and compressing product gross margin.
  • · Nine-month other income rose to $513.0 Million from $289.1 Million, a meaningful contributor to pre-tax income growth.
  • · Q3 2026 effective tax rate was about 18.5% versus about 20.8% a year earlier.
AMGEN INC 10-Q mixed materiality 8/10

04-11-2026

Amgen reported Q3 2026 total revenues of $10,365 Million, up 8.5% YoY from $9,557 Million, with net income of $3,864 Million (up 20.1% YoY) and diluted EPS of $7.08 (up 19.4% from $5.93). Nine-month revenues reached $29,037 Million (up 8.0%) and net income $8,058 Million (up 26.3%). Performance was mixed: Q3 cost of sales and SG&A declined, but R&D spending rose 11.1% and Other income, net fell 21.7% YoY in the quarter, while nine-month Other income, net dropped 49.1%.

  • · Q3 2026 Other operating expense fell sharply to $76 Million from $329 Million, a 76.9% decline.
  • · Total assets rose to $96,048 Million from $90,586 Million at December 31, 2025, while intangible assets declined to $19,536 Million from $22,276 Million.
  • · Accumulated deficit improved to $(19,807) Million from $(25,107) Million at year-end 2025.
  • · Current portion of long-term debt fell to $2,398 Million from $4,599 Million, and cash rose to $13,190 Million from $9,129 Million.
  • · Q3 2026 comprehensive income of $3,858 Million rose 15.6% YoY from $3,338 Million, though Q3 OCI turned negative at $(6) Million versus $122 Million a year earlier.
Bristow Group Inc. 10-Q mixed materiality 7/10

04-11-2026

Bristow Group reported Q3 2026 total revenues of $437.9 million, up 13.4% from $386.3 million in Q3 2025, and nine-month revenues of $1,238.4 million, up 11.2% year over year. However, net income attributable to Bristow fell 46.2% to $27.7 million for the quarter (from $51.5 million), and diluted EPS declined to $0.93 from $1.72. The company also completed a business acquisition during the period with total purchase consideration of $110.9 million.

  • · Q3 2026 net income attributable to Bristow decline (-46.2%) was driven by a $9.1M income tax expense versus an $11.8M tax benefit in Q3 2025
  • · Q3 2026 other, net expense was $1.0M versus $3.1M, while 9M 2026 other, net swung to a $15.3M expense from $25.9M income in 9M 2025
  • · Q3 2026 personnel expenses rose 9.9% and fuel costs rose 38.1%, pressuring margins
  • · Q3 2026 depreciation and amortization rose 66.2% to $29.5M, reflecting the acquisition and fleet additions
  • · The company recorded a $2.8M loss on debt extinguishment in 9M 2026 following $500M in new borrowings and $417.7M of debt repayments
  • · Acquisition purchase consideration of $110.9M included $23.4M goodwill and $15.1M intangibles; acquired net identifiable assets were $87.5M
  • · Share repurchases totaled $36.1M in 9M 2026 versus $9.1M in 9M 2025, and cash declined to $233.4M from $286.2M at year-end 2025
  • · Stockholders' equity increased to $1,095.5M, while total liabilities rose to $1,324.3M due to higher long-term debt
AVISTA CORP 10-Q mixed materiality 6/10

04-11-2026

Avista Corp reported Q3 2026 net income of $49 Million, up from $29 Million in Q3 2025 (+69%), with diluted EPS of $0.57 versus $0.36. Growth was driven largely by equity method earnings of $23 Million (vs. $1 Million), while total operating revenues rose 4.5% to $421 Million and income from operations increased 10% to $66 Million. However, resource costs rose 15% to $132 Million, and nine-month net income of $176 Million grew 44% while nine-month total operating revenues declined 1.9% to $1,404 Million.

  • · Q3 2026 utility revenues exclusive of alternative revenue programs rose to $422 Million from $411 Million, while alternative revenue programs swung to a $1 Million reduction from an $8 Million reduction
  • · Nine-month utility revenues exclusive of alternative revenue programs declined 4.7% to $1,367 Million, partly offset by alternative revenue programs swinging to a $37 Million benefit from a $4 Million reduction
  • · Q3 2026 other operating expenses declined to $121 Million from $125 Million
  • · Nine-month interest expense rose 6.2% to $120 Million from $113 Million
  • · Nine-month income tax expense rose to $26 Million from $15 Million, a 73% increase
  • · Nine-month equity method earnings were $46 Million versus a $10 Million loss in the prior year
  • · Nine-month cash used in investing activities increased to $525 Million from $373 Million, driven by higher utility capital expenditures
  • · Nine-month cash dividends paid rose to $124 Million from $119 Million; declared dividend per share increased to $1.478 from $1.470
  • · Long-term debt increased to $2,982 Million from $2,754 Million at year-end 2025, while short-term borrowings declined to $331 Million from $388 Million
  • · Nine-month proceeds from long-term debt issuance were $230 Million versus $140 Million in the prior year
CORE MOLDING TECHNOLOGIES INC 10-Q mixed materiality 6/10

04-11-2026

Core Molding Technologies reported Q3 2026 total net revenue of $90.2M, up 54.4% from $58.4M in Q3 2025, driven by a sharp rise in net tooling project revenue to $25.4M from $4.3M, while net production revenue grew 19.6% to $64.8M. However, profitability weakened: operating income fell 38.2% to $1.6M, net income declined 19.4% to $1.5M, and diluted EPS dropped from $0.22 to $0.17. For the nine months, revenue rose 6.2% to $211.5M but net income fell 51.9% to $3.9M as SG&A expense surged 30.5%.

  • · Q3 2026 SG&A expense rose 55.7% to $11,793K from $7,572K, outpacing revenue growth and compressing operating margin to 1.8% from 4.4%
  • · Cash fell from $38,058K to $5,437K (down 85.7%) while revolving debt rose to $4,810K from zero and long-term debt was fully repaid, lifting the balance sheet's reliance on working capital
  • · Accounts payable nearly doubled to $29,056K from $14,924K and receivables rose 31.8%, indicating heavier working capital build
  • · Q3 2026 comprehensive income turned negative at $(266)K versus $1,491K a year earlier, driven by a $(2,105)K unrealized foreign currency hedge loss
  • · Q3 2026 net interest expense was $39K versus $34K, while nine-month net interest expense rose to $185K from $18K
  • · Share repurchases in 2026 totaled $648K for open-market buybacks plus $612K for equity award net settlements, with outstanding shares rising modestly to 8,554,888
TALOS ENERGY INC. 10-Q mixed materiality 7/10

04-11-2026

Talos Energy reported a Q3 2026 net loss of $81.1 million (vs. $95.9 million loss in Q3 2025), while total revenues rose 32.4% YoY to $596.0 million driven by oil sales up 37.4% to $549.8 million. Nine-month net loss narrowed to $187.2 million from $291.7 million, but natural gas revenue declined 13.0% YoY for the nine-month period and price risk management produced a $263.6 million expense versus $75.2 million income a year earlier.

  • · Q3 2026 income tax expense of $47.1M reversed a Q3 2025 benefit of $24.2M, adding to the quarterly loss.
  • · Q3 2026 other income (expense) was a $30.1M expense versus $2.1M income in Q3 2025.
  • · Nine-month 2026 acquisition spending of $440.3M was made alongside $800M of new senior notes, with $653.1M of notes redeemed and a $37.4M loss on extinguishment of debt.
  • · Q3 2026 had no impairment charge, compared with $60.2M in Q3 2025; nine-month 2026 impairments totaled $145.0M versus $284.1M a year earlier.
  • · Accumulated deficit widened to $1,106.1M at September 30, 2026 from $918.4M at December 31, 2025.
  • · Cash and cash equivalents rose to $410.2M from $362.8M at year-end 2025.
HECLA MINING CO/DE/ 10-Q mixed materiality 8/10

04-11-2026

Hecla Mining Co. reported Q3 2026 sales of $394.8 million, up 25% from $316.0 million in Q3 2025, and net income of $149.6 million versus $100.7 million a year earlier. Nine-month sales rose 54% to $1,140.1 million, but nine-month net income of $248.4 million was sharply lower than expected by the strong quarter because of a $183.7 million loss from discontinued operations (largely the Hecla Quebec sale). Costs applicable to sales rose 16% in the quarter, and exploration and pre-development spending nearly doubled, offsetting part of the operating gains.

  • · Net income for the nine months was held down by a $183.7 million loss from discontinued operations, versus $39.3 million of income in the prior-year period, so continuing operations income of $432.1 million is the cleaner comparison.
  • · Depreciation, depletion and amortization declined 4.4% in Q3 2026 to $36.5 million, despite higher production volumes.
  • · General and administrative expense rose 12.3% in Q3 to $15.6 million and 21.1% over nine months to $46.5 million.
  • · Other operating expense, net fell 19.7% in Q3 to $2.8 million, but rose from $5.4 million to $10.9 million over nine months.
  • · Accounts receivable on the balance sheet fell from $170.2 million to $134.3 million (trade), while cash grew to $691.6 million from $241.6 million.
  • · Long-term debt was almost fully retired, falling from $263.2 million at December 31, 2025 to $7.1 million at September 30, 2026, after $263.0 million of nine-month repayments.
  • · Cash paid for income and mining taxes rose sharply to $83.2 million from $6.2 million a year earlier.
  • · Accumulated other comprehensive loss widened to $20.1 million from $3.3 million, driven by hedge-related losses.
  • · Retained earnings turned positive at $58.4 million from an accumulated deficit of $182.1 million at year-end 2025.
Ultragenyx Pharmaceutical Inc. 10-Q mixed materiality 7/10

04-11-2026

Ultragenyx reported Q3 2026 total revenues of $173M, up 8% YoY from $160M, and a net loss of $118M versus $180M a year ago, with R&D spend falling to $154M from $216M. However, the company remains deeply unprofitable on a nine-month basis (net loss of $395M vs. $446M, improved but still large), stockholders' deficit widened to $(376)M from $(80)M at year-end 2025, and cash plus marketable securities declined to roughly $401M from $937M at December 31, 2025, with operating cash burn of $337M for the nine months.

  • · Nine-month total revenues rose 12.2% to $523M from $466M, with product sales up 14.6% to $306M and royalty revenue up 9.0% to $217M.
  • · Net loss per share improved to $(1.16) in Q3 2026 from $(1.81) in Q3 2025; nine-month loss per share was $(3.89) vs. $(4.55).
  • · Non-cash interest expense on liabilities for sales of future royalties rose to $20M in Q3 (from $14M) and $63M for nine months (from $42M), a growing drag on reported results.
  • · Cash flow from financing was minimal at $13M for nine months, with no at-the-market equity raised in 2026 versus $80M in 2025; a $10M SAFE issuance was the main new financing.
  • · Accumulated deficit reached $(4,927)M, and the company's current liabilities of $389M exceed current assets of $544M only modestly, but the cash balance fell to $150M from $421M at year-end.
Toast, Inc. 10-Q mixed materiality 8/10

04-11-2026

Toast reported Q3 2026 total revenue of $1,981M, up 21.3% YoY from $1,633M, with net income of $169M versus $105M a year earlier (+61.0%) and diluted EPS of $0.29 versus $0.16. Gross profit rose 25.7% to $543M and operating income nearly doubled to $165M from $84M. Performance was mixed: hardware and professional services revenue grew only 2.3% to $45M, subscription services revenue (+30.0%) and financial technology solutions (+20.3%) drove growth, and the company repurchased $486M of Class A stock in the nine-month period, reducing diluted share count and cash balances.

  • · Cash paid to repurchase Class A common stock rose sharply to $486M in the nine months versus $54M a year earlier, drawing down cash balances.
  • · Inventories increased to $244M from $114M at year-end 2025, driven by a jump in finished goods and new raw materials, and consumed $131M of operating cash flow in the nine months.
  • · Credit loss expense rose to $87M in the nine months from $66M, a 31.8% increase that warrants monitoring given growth in loans held for investment ($145M purchased, $67M repaid).
  • · Net cash from investing activities turned to a $(172)M outflow versus $(20)M a year earlier, reflecting higher securities and loan purchases.
  • · Cash and cash equivalents declined to $1,203M from $1,353M at December 31, 2025, and total cash including customer funds and restricted cash fell to $1,433M from $1,583M at the start of the year.
  • · Stock-based compensation expense declined to $158M from $186M in the nine months, a 15.1% decrease.
  • · Restructuring expenses of $6M were recorded in Q3 2026 versus none in Q3 2025.
Astera Labs, Inc. 10-Q mixed materiality 9/10

04-11-2026

Astera Labs reported Q3 2026 revenue of $584.9M, up 153.6% YoY from $230.6M, and nine-month revenue of $1,285.7M, up 121.0% from $581.9M. Net income rose to $182.9M for the quarter (vs. $91.1M) and $416.3M year-to-date (vs. $174.2M). However, growth in operating expenses was steep: R&D rose 116.6% YoY in the quarter, and total comprehensive income was pressured by a $9.8M unrealized loss on marketable securities, with the nine-month unrealized loss at $17.5M versus a gain of $3.7M a year earlier.

  • · Gross margin compressed about 4 percentage points YoY (from 76.3% to 72.2%) in Q3 2026, despite strong revenue growth
  • · Research and development expense grew 116.6% YoY to $171.0M, outpacing revenue growth in percentage terms only slightly below it and absorbing a larger share of revenue
  • · Warrants contra revenue totaled $30.4M for the nine months (vs. $4.0M), a non-cash reduction to reported revenue
  • · Accounts receivable rose to $284.3M from $83.2M and inventory to $200.9M from $59.0M since December 31, 2025, indicating significant working capital build
  • · Q3 2026 income tax was a $9.1M provision versus a $24.3M benefit in Q3 2025; nine-month 2026 shows a $48.1M tax benefit
  • · Payments for business combinations of $69.2M in the first nine months of 2026, with goodwill rising to $91.6M from $19.0M
  • · Stock-based compensation of $199.5M in the nine months of 2026 (vs. $118.7M), a material non-cash expense
  • · Diluted weighted-average shares increased to 184.1M in Q3 2026 from 180.6M in Q3 2025
SYSCO CORP 10-Q mixed materiality 8/10

04-11-2026

Sysco reported first-quarter fiscal 2027 sales of $21,744 Million, up 2.8% YoY from $21,148 Million, and diluted EPS of $1.09 versus $0.99. Net earnings rose 10.5% to $526 Million, but this was flattered by a $234 Million gain on deal-contingent rate locks tied to the JRD (Jetro Restaurant Depot) acquisition financing; operating income actually fell 10.4% to $717 Million from $800 Million, and interest expense rose 51.7% to $261 Million from $172 Million.

  • · Core operating income declined 10.4% YoY to $717 Million, as operating expenses rose 7.6% against 3.8% gross profit growth; excluding the $234 Million rate-lock gain, pre-tax earnings would have been roughly $453 Million versus $600 Million a year earlier
  • · Interest expense rose 51.7% YoY to $261 Million, driven by debt issued to finance the JRD acquisition
  • · US Foodservice Operations generated $15,142 Million (about 70% of sales), International $4,168 Million, SYGMA $2,152 Million, and Other $282 Million
  • · Operating cash flow of $278 Million was substantially higher than $86 Million a year earlier, but investing outflows were modest and financing inflows of $1,150 Million reflect $1,000 Million in new common stock proceeds and $1,067 Million in new debt borrowings
  • · Share count increased with 12.3 Million common shares issued during the quarter; dividends declared were $0.55 per share versus $0.54 a year earlier
  • · Other comprehensive income of $108 Million was driven largely by a $104 Million change in cash flow hedges
Primoris Services Corp 10-Q negative materiality 8/10

04-11-2026

Primoris Services Corp reported Q3 2026 revenue of $1,952.4M, down 10.4% YoY from $2,178.4M, and net income of $51.3M, down 45.8% from $94.6M. Nine-month revenue fell 9.1% to $5,200.5M and nine-month net income fell 80.0% to $44.6M, while the company deployed $404.7M on acquisitions and $150.0M on stock purchases, contributing to a sharp drop in cash to $203.5M. Mixed signals include a rise in intangible assets and goodwill from acquisitions, but weaker profitability, margins, and operating cash flow.

  • · Gross margin compressed to about 10.5% in Q3 2026 versus about 10.8% in Q3 2025, and nine-month gross margin fell to about 8.1% from about 11.2%
  • · Interest expense, net more than doubled to $29.4M for nine months from $22.3M, and Q3 interest expense rose to $14.3M from $7.0M
  • · Effective tax burden shifted sharply: nine-month provision for income taxes was $19.3M on pre-tax income of $63.9M versus $88.9M on $312.1M a year earlier
  • · Q3 2026 included $101.5M in stock repurchases, and nine-month stock purchases totaled $150.0M, reducing shares outstanding by about 2.7% since year-end 2025
  • · Accounts receivable rose to $935.0M from $723.4M at year-end, and accounts payable declined to $720.8M from $744.3M, pressuring operating cash flow
  • · Cash, cash equivalents and restricted cash ended at $209.1M, down from $437.3M a year earlier, with net change in cash of -$332.2M for nine months
  • · Long-term debt increased to $741.8M from $409.0M, with $411.8M of debt issuance during nine months 2026
  • · Q3 2026 diluted EPS of $0.95 and nine-month diluted EPS of $0.82 compared with $1.73 and $4.07 a year earlier
QuidelOrtho Corp 10-Q mixed materiality 7/10

04-11-2026

QuidelOrtho reported Q3 2026 total revenues of $618.9M, down 11.6% from $699.9M a year earlier, and a net loss of $53.8M versus a $733.0M loss in Q3 2025 that included a $700.7M goodwill impairment. For the nine months, revenues fell 6.8% to $1,869.6M and the net loss narrowed to $238.5M from $1,001.1M, though operating cash flow was negative at $(124.0)M and total borrowings rose to roughly $2.94B.

  • · Cost of sales fell 9.6% in Q3 to $329.3M, cushioning the revenue decline; gross profit fell less than revenue
  • · Interest expense rose 20.2% in Q3 and 27.3% for nine months, reflecting higher borrowings
  • · Net cash used for operating activities widened sharply to $(124.0)M from $(26.7)M, driven by a $188.8M inventory build and $91.9M reduction in other liabilities
  • · Inventories rose to $642.7M from $577.6M at year-end, while accounts receivable declined to $375.5M from $417.0M
  • · Current portion of borrowings jumped to $424.4M from $178.3M, creating near-term refinancing exposure
  • · Accumulated other comprehensive income swung to $58.0M from $(15.4)M, aided by cash flow hedge gains
  • · Restructuring charges fell to $18.0M nine-month from $234.6M a year earlier
  • · Q3 2026 includes only a $12.5M asset impairment charge; no goodwill impairment versus $700.7M in Q3 2025
Flywire Corp 10-Q mixed materiality 8/10

04-11-2026

Flywire reported Q3 2026 revenue of $250.3M, up 25.1% YoY from $200.1M, and operating income of $52.8M versus $32.3M a year earlier, driven by higher payment processing volume. Net income was $74.5M, boosted by a $22.2M income tax benefit, compared with $29.6M in Q3 2025. However, the growth was partly offset by faster increases in payment processing costs (+29.9%) and general and administrative expenses (+23.1%), while selling and marketing expense was essentially flat (+1.6%).

  • · Q3 2026 net income was boosted by a $22.2M income tax benefit versus a $1.6M tax provision in Q3 2025; pre-tax income rose only 67.8% (from $31.2M to $52.4M), so the bottom-line jump is largely tax-driven
  • · Total other income turned to expense of $0.4M in Q3 2026 from $1.1M expense in Q3 2025, and foreign currency remeasurement was a loss of $0.5M versus a $0.6M loss a year earlier
  • · Interest income fell to $0.5M from $0.8M and interest expense declined to $0.5M from $1.2M year over year
  • · Nine-month 2026 foreign currency remeasurement moved to a $0.05M loss from a $6.9M gain in the prior-year period, a notable reversal
  • · Restructuring charges were $8.7M in the nine months of 2025 with none in 2026
  • · Cash and cash equivalents rose to $407.2M from $330.3M at year-end 2025, while short-term investments fell to $3.0M from $24.7M
  • · Accounts receivable increased 38.9% to $48.3M from $34.8M, and other assets rose to $72.3M from $33.3M
  • · Accumulated deficit narrowed to $(78.5)M from $(157.4)M at year-end 2025
  • · Non-voting common stock repurchased and retired for $29.0M in the nine months of 2026, versus no such repurchase in 2025
  • · Diluted weighted average share count rose to 129.7M in Q3 2026 from 127.7M in Q3 2025, reflecting continued dilution despite buybacks
Smurfit Westrock plc 10-Q mixed materiality 6/10

04-11-2026

Smurfit Westrock plc reported Q3 2026 net sales of $8,161 million, up 2.0% from $8,003 million in Q3 2025, while operating profit fell 7.4% to $487 million from $526 million and net income attributable to common shareholders declined 9.8% to $222 million from $246 million. Nine-month results were mixed: net sales rose 1.3% to $23,904 million and cash from operations declined 16.1% to $1,843 million, while net income attributable to common shareholders fell 37.5% to $376 million from $602 million. Diluted EPS for Q3 was $0.42 versus $0.47 a year earlier.

  • · Q3 2026 Q3 gross profit fell 8.2% to $1,440 million from $1,569 million despite higher net sales, indicating margin compression from higher cost of goods sold ($6,721M vs $6,434M).
  • · North America, the largest segment, saw Adjusted EBITDA fall 6.2% to $760 million from $810 million even as its net sales rose 2.4%.
  • · Europe, MEA and APAC net sales were essentially flat (+0.2%) while its Adjusted EBITDA declined 9.5% to $379 million from $419 million.
  • · LATAM was the only segment with growth in both net sales (+7.7%) and Adjusted EBITDA (+8.6%) in Q3.
  • · Nine-month net cash from operations fell 16.1% to $1,843 million, driven by a $711 million increase in accounts receivable.
  • · Total debt rose to about $14,049 million (current $842M plus non-current $13,207M) from $13,773 million at December 31, 2025, while cash fell to $723 million.
  • · Foreign currency translation was a $74 million loss in Q3 2026 versus a $66 million gain in Q3 2025, and nine-month OCI swung from a $1,156 million gain to a $55 million loss.
  • · Nine-month impairment and restructuring costs declined 44.7% to $199 million from $360 million, and Combination-related expenses dropped to $1 million from $72 million.
Hut 8 Corp. 10-Q mixed materiality 9/10

04-11-2026

Hut 8 Corp. reported Q3 2026 total revenue of $71.1M, down 14.9% from $83.5M in Q3 2025, and nine-month revenue of $217.0M, up 48.0% from $146.6M. Q3 operating income was $318.2M, driven largely by a $413.8M gain on digital assets, and net income attributable to Hut 8 was $131.1M versus $50.1M a year earlier. However, nine-month results show a net loss attributable to Hut 8 of $239.0M (versus $53.5M net income in 2025), as G&A rose to $257.4M and interest expense increased to $165.9M, while total liabilities climbed to $8.4B after a $7.7B loan/note proceeds inflow.

  • · Nine-month G&A expense rose to $257.4M from $77.1M, up roughly 234%, a material drag on earnings
  • · Interest expense rose to $105.5M in Q3 2026 from $8.6M in Q3 2025 following large debt issuance
  • · Total stockholders' equity attributable to Hut 8 rose to $1.56B from $1.42B at year-end 2025
  • · Q3 operating gains were primarily non-operating: the $413.8M digital asset gain drove the quarterly profit, while underlying operating revenue declined
  • · Power and Digital Infrastructure segment revenues fell sharply in Q3 2026 (down 87% and 73% respectively)
  • · Cash used in operating activities for nine months was $5.0M versus $81.9M a year earlier, while capital expenditures reached $1.1B
CVS HEALTH Corp 10-Q mixed materiality 8/10

04-11-2026

CVS Health reported Q3 2026 total revenues of $108,399 Million, up 5.4% YoY from $102,871 Million, and net income attributable to CVS Health of $2,172 Million versus a net loss of $(3,975) Million in Q3 2025, which included a $5,725 Million goodwill impairment. Nine-month revenues rose 6.3% to $314,921 Million and nine-month net income attributable to CVS Health reached $8,094 Million versus a $(1,175) Million loss a year earlier, with operating cash flow up to $15,318 Million from $7,249 Million. However, operating expenses were essentially flat (up 0.4% in Q3 and down 0.6% for nine months), interest expense declined only modestly, and accrued expenses and other current liabilities rose to $25,787 Million from $22,387 Million at year-end.

  • · Q3 2026 net income of $2,171 Million (total, before noncontrolling interests) compares with a net loss of $(3,990) Million in Q3 2025, which was driven by the $5,725 Million goodwill impairment.
  • · Q3 2026 premiums revenue was essentially flat, rising 0.9% to $34,566 Million, and services revenue rose only 0.8% to $3,961 Million.
  • · Q3 2026 health care costs were essentially flat at $32,316 Million, up 0.9% YoY from $32,020 Million.
  • · Net unrealized investment gains swung to a $(960) Million loss in Q3 2026 from a $192 Million gain in Q3 2025, weighing on comprehensive income.
  • · Cash and cash equivalents rose to $11,738 Million from $8,453 Million at year-end 2025, while long-term debt fell to $57,223 Million from $60,502 Million.
  • · Accrued expenses and other current liabilities increased to $25,787 Million from $22,387 Million at December 31, 2025, a notable rise in short-term obligations.
  • · Capital expenditures for the nine months were $2,357 Million, up from $2,048 Million a year earlier, a 15.1% increase.
Blackstone Secured Lending Fund 10-Q mixed materiality 8/10

04-11-2026

Blackstone Secured Lending Fund (BXSL) reported Q3 2026 net investment income after tax of $158.1 million ($0.68 per share), down 16.5% from $189.5 million ($0.82 per share) in Q3 2025, while net increase in net assets from operations was $116.8 million versus $132.4 million a year earlier (down 11.8%). Results were weighed down by a $231.4 million net realized loss in Q3 2026, though a $190.1 million net unrealized appreciation partly offset it. Net asset value per share fell to $25.25 from $26.92 at December 31, 2025, and distributable earnings swung to a $188.6 million deficit from a $197.2 million surplus.

  • · Q3 2026 net realized loss of $231.4M, driven by $234.9M of realized losses on non-controlled/non-affiliated investments, sharply offset the unrealized gain and drove the quarterly results lower
  • · Nine-month 2026 net unrealized depreciation of $101.3M and net realized loss of $257.9M compared with net realized loss of $25.4M and unrealized depreciation of $91.5M in the prior-year period
  • · Q3 2026 unrealized appreciation of $207.8M on non-controlled/non-affiliated investments contrasted with $39.8M of unrealized depreciation in Q3 2025
  • · Total debt declined to $7.04B from $8.08B at December 31, 2025, a reduction of approximately 12.9%
  • · Cash and cash equivalents fell to $142.5M from $289.6M at December 31, 2025, a decline of about 50.8%
  • · Interest expense rose 4.4% YoY in Q3 2026 to $98.9M from $94.7M, even as total investment income fell 12.1%
  • · Income-based incentive fees fell 46.1% YoY in Q3 to $16.8M from $31.3M, partially cushioning the NII decline
ESAB Corp 10-Q mixed materiality 8/10

04-11-2026

ESAB Corporation reported Q3 2026 net sales of $824.5M, up 13.3% YoY from $727.8M, and nine-month net sales of $2,377.7M, up 12.1% YoY. Net income attributable to ESAB fell 20.8% YoY in the quarter to $38.9M, and diluted EPS from continuing operations declined from $1.04 to $0.61, as SG&A rose sharply and operating income fell 13.7% YoY to $91.9M. Growth was driven by acquisitions, which absorbed $1.47B in cash during the nine months, while the company also issued $1.0B in Senior Notes and common and mandatory convertible preferred equity.

  • · Operating income fell 13.7% in Q3 despite 13.3% sales growth, as SG&A rose 39.2% YoY to $220.4M from $158.3M.
  • · Restructuring and other related charges rose to $11.3M in Q3 from $4.3M and to $39.8M for nine months from $10.2M.
  • · Interest expense and other, net rose 54.9% in Q3 to $36.5M from $23.6M, and 51.1% for nine months to $92.7M.
  • · Income tax expense in Q3 fell to $13.3M from $17.7M, while nine-month net income from continuing operations fell 37.2% to $130.4M from $207.7M.
  • · Nine-month operating cash flow declined 6.4% to $153.0M from $163.5M despite higher net sales.
  • · Goodwill rose to $2.74B from $1.95B and intangible assets rose to $1.35B from $0.67B, reflecting acquisition-driven balance sheet growth.
  • · Long-term debt rose to $2.32B from $1.23B at December 31, 2025, following the $1.0B Senior Notes issuance and revolver borrowings.
  • · Preferred stock dividends of $2.8M in Q3 and $4.2M for nine months reduced net income available to common stockholders to $36.1M in Q3.
UNITED THERAPEUTICS Corp 10-Q mixed materiality 7/10

04-11-2026

United Therapeutics reported Q3 2026 total revenues of $832.5M, up 4.1% YoY from $799.5M, and nine-month revenues of $2,397.3M, roughly flat versus $2,392.5M. However, Q3 net income fell 23.7% to $258.6M from $338.7M, and diluted EPS dropped to $5.71 from $7.16, as R&D expense more than doubled to $279.2M from $127.5M. The company repurchased $2,000.0M of stock over nine months, reducing shares outstanding to 42.4M from 43.6M at year-end 2025.

  • · Cost of sales fell to $99.1M in Q3 2026 from $100.9M, while nine-month cost of sales rose 18.1% to $332.0M from $281.0M
  • · SG&A declined 19.8% in Q3 to $146.4M from $182.6M, partly offsetting R&D growth
  • · Interest income fell 27.4% in Q3 to $33.7M, reflecting lower invested balances
  • · Income tax expense rose to $114.2M in Q3 from $99.3M despite lower pre-tax income, lifting the effective tax rate to about 30.6%
  • · Property, plant, and equipment grew to $2,041.9M from $1,729.7M, a 18.0% increase since year-end 2025
  • · Accumulated other comprehensive loss swung to $(30.3)M from a $0.9M gain at year-end 2025
  • · Total liabilities declined to $758.1M from $783.8M while total assets fell 10.8% to $7,034.1M
Palmer Square Capital BDC Inc. 10-Q mixed materiality 7/10

04-11-2026

Palmer Square Capital BDC Inc. reported a Q3 2026 net investment income of $11,635,680, down 14.7% from $13,641,070 in Q3 2025, and a net increase in net assets from operations of $14,007,567 versus $3,353,424 a year earlier. However, for the nine months ended September 30, 2026, the company recorded a net decrease in net assets from operations of $(14,779,215), compared with a net increase of $2,134,189 in the prior-year period, while net asset value per share fell to $13.34 from $14.85 at December 31, 2025.

  • · Net realized losses widened to $(18.62M) for nine months 2026 from $(12.88M) in the prior-year period, and Q3 2026 realized losses were $(4.61M) versus $(1.24M) a year earlier.
  • · Net change in unrealized losses for nine months 2026 was $(30.88M), compared with $(25.38M) in the prior-year period, indicating continued portfolio markdowns.
  • · Interest income fell to $24.81M in Q3 2026 from $30.43M in Q3 2025, a decline of roughly 18.5%, reflecting lower investment income.
  • · Net assets declined by $60.69M in nine months 2026, driven by $35.00M in distributions, $10.91M in share repurchases, and the net operating loss.
  • · Total debt investments at fair value were $1,006.39M (249.5% of net assets) in the first schedule, while equity and other investments were $20.04M (4.9% of net assets), indicating high leverage relative to equity.
  • · Credit facilities decreased to $355.89M from $414.44M and notes were roughly flat at $300.73M, while the company made $71.98M in credit facility repayments during the nine months.
  • · Cash flow from operations remained positive at $107.63M for nine months 2026, slightly above $104.91M in the prior-year period, supporting distributions and debt paydown.
  • · Distributions payable were $11.49M at September 30, 2026, versus $13.44M at December 31, 2025.
Pharmaceutical Resource Technology, Inc. 10-Q mixed materiality 5/10

04-11-2026

Pharmaceutical Resource Technology, Inc. reported 9-month revenue of $8.89M for the period ended September 30, 2026, up 15.5% from $7.69M a year earlier, with net profit falling 73.7% to $0.13M from $0.51M as cost of revenue rose 34.2% and G&A increased 9.7%. Q3 2026 showed a sharp swing to profitability, with net profit of $0.46M versus a $0.37M loss in Q3 2025, driven by a 44.0% revenue increase and lower G&A. All revenue and most expenses are related-party transactions with Superbee.

  • · 9-month cost of revenue rose 34.2% (from $3.54M to $4.75M), outpacing 15.5% revenue growth and compressing gross profit by 0.3% to $4.14M
  • · Gross profit for 9 months was essentially flat, declining from $4.15M to $4.14M
  • · Cash flow from operations rose to $2.66M from $2.19M, while cash balance nearly doubled to $5.15M despite $0.36M in intangible asset purchases
  • · Repayment of $2.80M in debt owed to directors in 2025 did not recur in 2026, and no new equity or loan proceeds were raised in 2026
  • · Related-party exposure is significant: Superbee accounts for all revenue, most cost of revenue and G&A, and a $1.00M receivable and $0.09M trade payable
  • · Net profit in the 9-month period was reduced by a $5,830 income tax provision in 2026, versus none in 2025
  • · Q3 2026 G&A fell 18.0% YoY to $1.17M, which drove the Q3 profit swing despite a 44.0% revenue increase
BRINKS CO 10-Q mixed materiality 8/10

04-11-2026

Brink's reported Q3 2026 revenues of $1,374.6 million, up 3.0% YoY from $1,335.0 million, and nine-month revenues of $4,142.0 million, up 6.7% from $3,882.2 million. However, profitability weakened sharply: Q3 operating profit fell 14.1% to $131.0 million from $152.4 million, net income attributable to Brink's dropped 60.0% to $14.5 million from $36.3 million, and diluted EPS fell to $0.35 from $0.86. Nine-month net income attributable to Brink's declined 30.8% to $91.0 million, and nine-month operating cash flow fell 41.8% to $154.8 million from $265.9 million.

  • · Q3 2026 cost of revenues rose to $1,040.3 million from $990.4 million, and SG&A rose 12.6% to $224.0 million from $199.0 million, outpacing revenue growth.
  • · Q3 2026 interest and other nonoperating expense was $(24.7) million versus $1.5 million income in Q3 2025, and the effective tax provision was $23.7 million versus $53.0 million.
  • · Nine-month 2026 comprehensive income attributable to Brink's fell 72.7% to $72.6 million from $265.8 million, driven by foreign currency translation losses.
  • · Q3 2026 Latin America was the strongest growing segment (+8.4% YoY), while Q3 2026 Cash and Valuables Management declined 2.2% YoY, the core segment's weakness being offset by DRS and AMS growth of 16.0%.
  • · Cash derecognized upon deconsolidation of the Malaysia business totaled $62.4 million in the nine-month period, and the Q3 2026 disposition of noncontrolling interests reduced noncontrolling equity by $47.0 million.
  • · Share repurchases fell to $30.2 million in the nine-month 2026 period from $153.6 million in the prior year, while quarterly dividends per share rose to $0.2550 from $0.2550 (flat) with nine-month dividends at $0.7650 versus $0.7525.
  • · Receivables rose $96.1 million since January 1, 2026 to $862.1 million, and restricted cash held for customers increased $106.2 million in cash-flow terms, weighing on operating cash flow.
  • · Q3 2026 segment operating profit totaled $244.4 million, with North America at $61.5 million, Latin America at $64.6 million, Europe at $65.2 million, and Rest of World at $53.1 million.
RYTHM, Inc. 10-Q mixed materiality 8/10

04-11-2026

RYTHM, Inc. reported Q3 2026 revenue of $23,857 thousand, up from $4,043 thousand in Q3 2025, and nine-month revenue of $60,163 thousand versus $6,623 thousand a year earlier. Q3 operating income was $981 thousand versus an operating loss of $(8,888) thousand, but the company still posted a Q3 net loss of $(533) thousand, with nine-month net income of $20,573 thousand driven largely by a $26,798 thousand non-cash income tax benefit from the release of a valuation allowance. Interest expense rose sharply and selling, general and administrative expenses grew substantially, while the balance sheet showed cash rising to $48,244 thousand and related-party debt of $72,000 thousand now classified as current.

  • · Q3 2026 gross margin was approximately 76.9% (gross profit $18,351K on revenue $23,857K), versus about 34.0% in Q3 2025.
  • · Net loss per share for Q3 2026 was $(0.07) basic and diluted, versus $(5.33) in Q3 2025, reflecting a much larger share count after issuances.
  • · Weighted average basic shares rose to 7,722,524 in Q3 2026 from 2,002,568 in Q3 2025, indicating substantial dilution from share issuances.
  • · Accounts receivable - related party and inventory both declined materially, with inventory down about 66% from December 31, 2025.
  • · Related-party debt of $72,000K was reclassified entirely to current liabilities, while non-current related-party debt fell to zero from $45,000K, raising near-term refinancing pressure.
  • · Total current liabilities rose to $91,910K from $42,960K, exceeding current assets of $59,189K.
  • · Nine-month 2026 operating cash flow of $16,026K was supported by working-capital inflows and non-cash items, versus $(20,519)K used in the prior-year period.
  • · Pre-funded warrants were issued in lieu of cash interest totaling $6,813K for the nine months ended September 30, 2026, versus $1,794K a year earlier.
  • · Depreciation and amortization increased to $10,444K for nine months 2026 from $2,530K, consistent with the scale-up of the business.
  • · Accumulated deficit improved to $(320,227)K from $(340,800)K at year-end 2025.
CPI Card Group Inc. 10-Q mixed materiality 6/10

04-11-2026

CPI Card Group reported Q3 2026 revenue of $158,357 Thousand, up 14.8% YoY from $137,966 Thousand, and net income of $5,019 Thousand versus $2,308 Thousand a year earlier. Nine-month revenue rose 16.4% to $454,646 Thousand, and cash from operations increased to $57,252 Thousand from $19,911 Thousand. Performance was mixed: cash and cash equivalents fell 30.1% year-to-date to $15,177 Thousand, and total stockholders' deficit, while narrowing, remained negative at $(7,031) Thousand.

  • · Basic EPS rose to $0.43 in Q3 2026 from $0.20 in Q3 2025; diluted EPS rose to $0.41 from $0.19.
  • · Selling, general and administrative expenses increased 23.7% in Q3 2026 to $34,597 Thousand from $27,975 Thousand, outpacing gross profit growth of 22.6%.
  • · Inventories fell to $64,444 Thousand from $72,243 Thousand, with raw materials down $12,577 Thousand, contributing to a $7,900 Thousand operating cash inflow.
  • · Capital deficit improved to $(100,905) Thousand from $(102,091) Thousand, and accumulated earnings rose to $93,862 Thousand from $84,747 Thousand.
  • · Interest paid was $29,876 Thousand in nine months 2026 versus $31,099 Thousand in 2025, and the company made net debt repayments of $36,500 Thousand.
  • · Equity in losses of unconsolidated affiliates totaled $(458) Thousand for nine months 2026, versus none in 2025.
  • · Financing lease additions were $10,113 Thousand in 2026 versus $11,128 Thousand in 2025, and machinery under financing leases rose to $57,255 Thousand.
  • · Total liabilities of $391,884 Thousand exceeded total assets of $384,853 Thousand, so the company remains in a stockholders' deficit position.
SharkNinja, Inc. 10-Q mixed materiality 8/10

04-11-2026

SharkNinja reported Q3 2026 net sales of $1,976.4M, up 21.2% YoY from $1,630.2M, and net income of $338.4M, up 79.3% from $188.7M. Nine-month net sales rose 20.0% to $5,154.7M, while nine-month net income grew 32.1% to $589.6M. Growth was accompanied by higher operating expense intensity: total operating expenses rose 31.1% in the quarter, and G&A increased 55.0%, while cash and cash equivalents declined 37.3% since year-end 2025 as working capital (receivables and inventories) expanded.

  • · Gross margin expanded to roughly 59.2% in Q3 2026 from 50.1% in Q3 2025, while cost of sales declined 0.8% YoY despite 21.2% sales growth
  • · Nine-month other (expense) income swung from +$33.1M income in 2025 to -$22.8M expense in 2026, a headwind to pre-tax income
  • · Q3 2026 interest income turned positive at $3.1M versus $12.8M net expense in Q3 2025, a favorable swing
  • · Q3 2026 effective tax rate was about 23.3% versus 22.7% in Q3 2025; nine-month tax provision rose 31.1% to $162.9M
  • · Company repurchased 1,301,500 treasury shares for $169.7M year-to-date, including 293,132 shares ($50.0M) in Q3 2026
  • · Accounts receivable rose 26.5% and inventories rose 42.5% since December 31, 2025, consuming working capital while cash declined 37.3%
  • · Total debt (current plus noncurrent) was about $706.6M at September 30, 2026, down from $736.1M at December 31, 2025
Option Care Health, Inc. 10-Q mixed materiality 6/10

04-11-2026

Option Care Health reported Q3 2026 net revenue of $1,493.5M, up 4.1% YoY from $1,435.0M, and net income of $57.4M, up 10.8% from $51.8M; diluted EPS was $0.38 versus $0.32. Nine-month net revenue rose 2.4% to $4,286.6M, while nine-month operating income was essentially flat at $246.9M versus $246.4M, and mixed performance is evident as Commercial payer revenue grew only 2.5% for the nine months and cash-flow-driven share repurchases continued.

  • · Commercial payer revenue was nearly flat (+1.0% for nine months, +2.5% in Q3) while Government payer revenue grew 11.4% for nine months.
  • · Nine-month operating income was flat (+0.2%) despite 2.4% revenue growth, as SG&A and D&A grew faster than gross profit.
  • · Gross margin slightly compressed: nine-month gross profit rose only 1.1% on 2.4% revenue growth.
  • · Operating cash flow rose 28.6% to $286.2M, supported by a $63.1M inventory reduction.
  • · Share count fell about 7% year over year (basic weighted shares 149.8M vs 161.8M in Q3), driven by $170.5M of buybacks in nine months.
  • · Treasury stock grew to $987.3M from $818.2M at year-end 2025, reducing stockholders' equity to $1,324.5M from $1,326.4M.
  • · Interest expense fell 9% for nine months to $40.2M, and total debt principal repayments were modest at $5.1M.
Flutter Entertainment plc 10-Q mixed materiality 8/10

04-11-2026

Flutter Entertainment reported Q3 2026 revenue of $3,874 Million, up 2.1% YoY from $3,794 Million, but posted a net loss attributable to Flutter shareholders of $862 Million versus $690 Million in the prior-year quarter, driven by a $541 Million goodwill impairment and higher sales and marketing and technology costs. For the nine months, revenue grew 7.4% to $12,504 Million while the operating loss widened to $1,256 Million from $222 Million, though U.S. sportsbook revenue declined 4.4% YoY over the nine-month period and the balance sheet shows goodwill down to $15,046 Million from $15,825 Million.

  • · Nine-month U.S. sportsbook revenue fell 4.4% YoY to $3,000 Million while U.S. iGaming grew 13.5% to $1,713 Million
  • · Q3 2026 International segment revenue was essentially flat at $2,419 Million (+0.2% YoY), with International iGaming up 0.7% and International sportsbook down 1.9%
  • · Q3 2026 operating loss widened 42.8% to $1,191 Million, reflecting the $541 Million goodwill impairment, sales and marketing expense up 18.9%, and technology/R&D expense up 27.5%
  • · Nine-month operating loss was $1,256 Million versus a $222 Million loss in the prior year despite revenue growth
  • · Total equity declined to $8,156 Million from $9,274 Million at December 31, 2025, with accumulated other comprehensive loss widening to $(1,242) Million
  • · Operating cash flow for nine months rose to $904 Million from $756 Million, while net financing outflow of $243 Million reflected $264 Million in share repurchases and taxes withheld
  • · Cash and cash equivalents declined to $1,708 Million from $1,828 Million, while long-term debt was broadly stable at $12,143 Million (prior: $12,157 Million)
  • · Intangible assets declined to $5,952 Million from $7,019 Million, consistent with amortization and impairment charges

Get daily alerts with 10 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: US Earnings Financial Results SEC Filings

🇺🇸 More from United States

View all →